This site is intended for healthcare professionals only
LoginRegister
Dr Reddys, Zydus recall products in US over manufacturing issuesZydus, Dr Reddy's recall products in US over manufacturing issues
Aurobindo Pharma arm Unit IV gets 5 USFDA observationsBiocon gets 1 USFDA observation for Cranbury site
Senores Pharma to buy Apnar Pharma at enterprise value of Rs 91 croreNovo Nordisk to acquire Akero Therapeutics for up to USD 5.2 billion
Lupin unveils Liraglutide Injection in US for diabetesLupin gets 1 USFDA observation for Somerset facility
Kerala RCC Blacklists Globela Pharma After Brain Cancer Drug Found in Wrong PackagingKerala RCC Blacklists Globela Pharma After Brain Cancer Drug Found in Wrong Packaging
CDSCO Panel Clears Bristol Myers Yervoy for Two New Cancer IndicationsBristol myers Squibb to acquire Orbital for USD 1.5 billion
Natco Pharma appoints G Vijay Kiran Kumar as VP- Corporate Quality Assurance (Formulations)Natco Pharma appoints G Vijay Kiran Kumar as VP- Corporate Quality Assurance (Formulations)
PLI Schemes reduce API import dependence: Govt tells ParliamentJubilant HollisterStier unveils high speed Isolator based Line at Spokane facility in US
Zydus Lifesciences bags USFDA nod for high BP tabletUSFDA Raises Compliance Concerns at Hetero Labs' Nakkapalli Facility
Pharmacy Recruitment in Bihar Stalled: Union Demands Immediate Action on Pending Document VerificationPharmacy Recruitment in Bihar Stalled: Union Demands Immediate Action on Pending Document...
SEC Asks Enzene Biosciences to Revise Phase III Trial Protocol for Nivolumab BiosimilarSEC Asks Enzene Biosciences to Revise Phase III Trial Protocol for Nivolumab Biosimilar
court orderMurder of Amravati Chemist a 'Terror Act', Rules NIA Court, Denies Bail to Accused
X